SHS Gesellschaft für Beteiligungsmanagement mbH

News Current page: 2

Current news of SHS and our portfolio companies

23. October 2024 - Newsletter

Simulands launches simuGO on the market

SHS portfolio company Simulands, based in Zurich, has unveiled a ground-breaking portable and ultra-lightweight medical simulator simuGO, designed to enhance product demonstrations in the cardiology field. This innovative device, which can be set up in just 20 seconds, enables on-the-go and in-office demonstrations, significantly improving engagement and understanding of innovative and complex cardiology medical technology […]

Read more
7. October 2024 - SHS News

Healthcare Specialist SHS Capital, together with its Partners, invests further capital in Develco to meet exceptional market demand

Tuebingen / 07.10.2024 SHS Capital is pleased to announce a significant investment alongside its limited partners in one of its portfolio companies, Develco. SHS Capital has been a committed investor since 2020 and is pleased to have offered its LPs the opportunity to co-invest in Develco. Develco is a specialty pharma company focused on the […]

Read more
23. April 2024 - Newsletter

Results confirmed: Selfapy’s medical product also shows efficacy in men with generalised anxiety disorder

In December 2023, the Federal Institute for Drugs and Medical Devices (BfArM) extended the reimbursement of Selfapy’s online course for generalised anxiety disorder to men. The BfArM thus confirms the results of additional real-world evidence (RWE), which shows that Selfapy’s product also significantly reduces anxiety symptoms and improves health-related quality of life in men with […]

Read more
Previous1
2
34
...
Next Last